UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.026

Sortiert nach

Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models

Scientific reports, 2021-09, Vol.11 (1), p.17557-17557, Article 17557

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

British journal of cancer, 2016-05, Vol.114 (10), p.1084-1089

2016

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of intrahepatic Yttrium-90 microsphere radioembolisation in combination with intravenous cisplatin for uveal melanoma liver-only metastases

Annals of oncology, 2018-11, Vol.29, p.ix105-ix105

2018

Link zum Volltext

Verfügbarkeit prüfen

The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration

International Journal of Cell Biology, 2013, Vol.2013, p.797914-15

2013

Link zum Volltext

Verfügbarkeit prüfen

Rab-dependent cellular trafficking and amyotrophic lateral sclerosis

Critical reviews in biochemistry and molecular biology, 2018-11, Vol.53 (6), p.623-651

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract

Human pathology, 2013-02, Vol.44 (2), p.164-172

2013

Link zum Volltext

Verfügbarkeit prüfen

Release Studies on Niosomes Containing Fatty Alcohols as Bilayer Stabilizers Instead of Cholesterol

Journal of colloid and interface science, 2002-07, Vol.251 (2), p.360-365

2002

Link zum Volltext

Verfügbarkeit prüfen

Non‐HIV‐associated Kaposi sarcoma in an immunosuppressed melanoma patient treated with dabrafenib

Journal of clinical pharmacy and therapeutics, 2016-06, Vol.41 (3), p.354-356

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of haematology/oncology patients admitted to intensive care unit at The Canberra Hospital

Internal medicine journal, 2014-11, Vol.44 (11), p.1087-1094

2014

Link zum Volltext

Verfügbarkeit prüfen

Response to MAPK pathway inhibitors in BRAF V600M‐mutated metastatic melanoma

Journal of clinical pharmacy and therapeutics, 2015-02, Vol.40 (1), p.121-123

2015

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib‐induced hyperammonemic encephalopathy

Journal of clinical pharmacy and therapeutics, 2014-08, Vol.39 (4), p.446-448

2014

Link zum Volltext

Verfügbarkeit prüfen

Rapunzel syndrome resulting in gastric perforation

Annals of the Royal College of Surgeons of England, 2016-01, Vol.98 (1), p.e6

2016

Link zum Volltext

Verfügbarkeit prüfen

Expert witness

Indian journal of anaesthesia, 2011-07, Vol.55 (4), p.421-422

Parakh, Sc

2011

Link zum Volltext

Verfügbarkeit prüfen

Medicolegal article

Indian journal of anaesthesia, 2010-01, Vol.54 (1), p.39-39

Parakh, S C

2010

Link zum Volltext

Verfügbarkeit prüfen

Vicarious liability

Indian journal of anaesthesia, 2010-11, Vol.54 (6), p.591-591

Parakh, S

2010

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism: Role of the Clinical Laboratory in Diagnosis and Management

The journal of applied laboratory medicine, 2019-03, Vol.3 (5), p.870-882

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of a Melting Tablet Containing Promethazine HCl Against Motion Sickness

AAPS PharmSciTech, 2008, Vol.9 (3), p.1006-1015

2008

Link zum Volltext

Verfügbarkeit prüfen

Legal Aspects of Anaesthesia Practice

Indian journal of anaesthesia, 2008-05, Vol.52 (3), p.247-257

Parakh, S

2008

Link zum Volltext

Verfügbarkeit prüfen

1248P Immune checkpoint inhibition with chemoradiotherapy (CRT) in stage III non-small cell lung cancer: A systematic review of current evidence and meta-analysis of safety results

Annals of oncology, 2020-09, Vol.31, p.S808-S808

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of bilirubin interference in three commonly used digoxin assays

Clinical biochemistry, 2019-01, Vol.63, p.102-105

2019

Link zum Volltext

Verfügbarkeit prüfen

1194TiP AdvanTIG-205: Phase II trial of ociperlimab (OCI) + tislelizumab (TIS) + chemotherapy (chemo) in first line (1L) treatment of patients (pts) with locally advanced (LA), unresectable, or metastatic non-small cell lung cancer (mNSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1094

2022

Link zum Volltext

Verfügbarkeit prüfen

1517P - Impact of radiotherapy on efficacy of anti-programmed death 1 (PD-1) antibodies in metastatic NSCLC

Annals of oncology, 2019-10, Vol.30, p.v622-v622

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of radiotherapy on efficacy of anti-programmed death 1 (PD-1) antibodies in metastatic NSCLC

Annals of oncology, 2019-10, Vol.30, p.v622

2019

Link zum Volltext

Verfügbarkeit prüfen

OA08.06 Implementation of a Nurse-led Geriatric Oncology Assessment Model in the Lung Cancer Care Pathway

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S24-S25

2022

Link zum Volltext

Verfügbarkeit prüfen

590P A retrospective study of the prevalence and clinical outcomes of KRAS G12C mutated advanced non-small cell lung cancer (NSCLC) in Australian patients (pts)

Annals of oncology, 2023-11, Vol.34, p.S1700

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.026

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(778)
Mit Volltextzugriff
(901)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(492)
Life Sciences & Biomedicine
(389)
Humans
(288)
Male
(137)
Female
(125)
Middle Aged
(91)
Technology
(90)
Adult
(78)
Medicine
(74)
Aged
(66)
Medicine & Public Health
(65)
Pediatrics
(64)
Cardiovascular System & Cardiology
(54)
Radiology, Nuclear Medicine & Medical Imaging
(50)
Biological And Medical Sciences
(49)
General & Internal Medicine
(49)
Oncology
(48)
Medical Sciences
(47)
Medicine, General & Internal
(46)
Computer Science
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

A pilot study of intrahepatic Yttrium-90 microsphere radioembolisation in combination with intravenous cisplatin for uveal melanoma liver-only metastases

The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration

Rab-dependent cellular trafficking and amyotrophic lateral sclerosis

Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract

Release Studies on Niosomes Containing Fatty Alcohols as Bilayer Stabilizers Instead of Cholesterol

Non‐HIV‐associated Kaposi sarcoma in an immunosuppressed melanoma patient treated with dabrafenib

Outcomes of haematology/oncology patients admitted to intensive care unit at The Canberra Hospital

Response to MAPK pathway inhibitors in BRAF V600M‐mutated metastatic melanoma

Regorafenib‐induced hyperammonemic encephalopathy

Rapunzel syndrome resulting in gastric perforation

Expert witness

Medicolegal article

Vicarious liability

Venous Thromboembolism: Role of the Clinical Laboratory in Diagnosis and Management

Development of a Melting Tablet Containing Promethazine HCl Against Motion Sickness

Legal Aspects of Anaesthesia Practice

1248P Immune checkpoint inhibition with chemoradiotherapy (CRT) in stage III non-small cell lung cancer: A systematic review of current evidence and meta-analysis of safety results

Characterization of bilirubin interference in three commonly used digoxin assays

1194TiP AdvanTIG-205: Phase II trial of ociperlimab (OCI) + tislelizumab (TIS) + chemotherapy (chemo) in first line (1L) treatment of patients (pts) with locally advanced (LA), unresectable, or metastatic non-small cell lung cancer (mNSCLC)

1517P - Impact of radiotherapy on efficacy of anti-programmed death 1 (PD-1) antibodies in metastatic NSCLC

Impact of radiotherapy on efficacy of anti-programmed death 1 (PD-1) antibodies in metastatic NSCLC

OA08.06 Implementation of a Nurse-led Geriatric Oncology Assessment Model in the Lung Cancer Care Pathway

590P A retrospective study of the prevalence and clinical outcomes of KRAS G12C mutated advanced non-small cell lung cancer (NSCLC) in Australian patients (pts)

Suchergebnisse filtern